Hard proof of how well Oracle's main profit engine is running - join our Conference Call at 2pm CT Wednesday October 22nd. HIDE

Bad News For Pharma In World’s Second-Biggest Market

Pharma companies have great plans for emerging markets like China and India, with their billions of potential customers. As Ed Silverman has written, companies like Pfizer (PFE), Merck (MRK), Eli Lilly (LLY), Bristol Myers-Squibb (BMY), GlaxoSmithKline (GSK) and Sanofi (SNY) have regularly mentioned these as avenues for growth and ways to combat problems like patent expirations and pricing pressures in developed nations.

But emerging markets aren’t proving a panacea. See stories here, here, here and here. And in the latest installment of bad news, a panel of Indian ministers wants to regulate the prices of 348 drugs, up from the 74 drugs they were previously considering, Reuters reports. The question for investors: how high are the emerging markets-related expectations built into this stock chart?

PFE Chart

PFE data by YCharts

From the editors of YCharts.YCharts Pro Investor Service includes professional stock charts, stock ratings and portfolio strategies.

Read more articles about: Company News  

blog comments powered by Disqus
Advertisement

Search Articles

Subscribe to YCharts Analysis

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.